Trial Profile
Efficacy and safety of bortezomib in combination with R-CHOP therapy in patients with indolent non-Hodgkin's lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 17 May 2016 New trial record